What has Changed?
Same policy. Same 25% premium increase.
In 2019, the Administration attempted to remove a powerful tool used to negotiate lower prescription drug costs. Studies, including federal government studies, revealed the proposal would increase Medicare Part D premiums 25% and cost taxpayers up to $400 billion – while doing nothing to actually lower prescription drug prices.
President Trump rejected that proposal in 2019, and under his leadership Medicare premiums remain low for seniors.
In 2020, the Administration revived the same proposal.
Why now, during a pandemic and economic downturn, and right before an election, would they add costs to seniors and taxpayers?